Intraoperative calcitonin stimulation testing in the surgical treatment of C-cell disease.
CONCLUSION: The results encourage the use of an individualised approach on patients with MTC/CCH, e.g. to be less radical surgically in cases of negative iCST, and to be more radical in those patients with persistent increase of serum calcitonin. The absence of post-stimulation calcitonin elevation in iCST seems to be a good prognosis indicator in patients with an early-stage C-cell disease, but longer follow-up is needed.
PMID: 29200250 [PubMed - as supplied by publisher]
Source: Neuroendocrinology Letters - Category: Endocrinology Tags: Neuro Endocrinol Lett Source Type: research
More News: Brain | Cancer & Oncology | Carcinoma | Endocrinology | Hormones | Neurology | Study | Thyroid | Thyroid Cancer | Thyroidectomy